The first win for 'Xarelto Plaintiff'
The first win for 'Xarelto Plaintiff'
Introduction
The first Philadelphia Xarelto bellwether trial, convened in the Philadelphia's Complex Litigation Center, not only went in favor of the plaintiff but also was the first win for a 'Xarelto Plaintiff' after three straight losses in the federal court. In response to the plaintiff's allegations that Xarelto caused severe bleeding after being prescribed by her doctor and inadequate warnings provided by the drug makers, the state court jury awarded $29 million in damages against the defendants Johnson & Johnson and Bayer AG.
Xarelto lawsuits are centralized in the U.S. District Court for the Eastern District of Louisiana before Judge Eldon E. Fallon as a part of MDL- 2592 Xarelto Products Liability Litigation. Currently, more than 22,000 Xarelto cases are pending in several courts across the country. With the first win proving that a Xarelto prescription caused internal bleeding and no adequate warnings provided by the manufacturers, preparation will begin for the remaining Xarelto cases.
Comments
Latest News
Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors
Categories: E-Cigarette: JUUL
As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.
A study published in Environmental Health Perspectives in…
Appeals Court Upholds $611M Roundup Verdict
Categories: Roundup
A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.
The case involved three plaintiffs from New…
Valsartan “Wave 2” Bellwether Trial Schedule Set by Court
Categories: Valsartan
As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.
This move comes in anticipation of the possibility that parties may…